rts logo

Solid Biosciences Inc (SLDB) Review – Making Smarter Decisions

Solid Biosciences Inc (NASDAQ: SLDB) is 33.25% higher on its value in year-to-date trading and has touched a low of $2.88 and a high of $15.05 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The SLDB stock was last observed hovering at around $5.29 in the last trading session, with the day’s gains setting it 0.04%.

Currently trading at $5.33, the stock is 25.38% and 34.38% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.08 million and changing 0.76% at the moment leaves the stock -17.00% off its SMA200. SLDB registered -43.89% loss for a year compared to 6-month loss of -43.66%.

The stock witnessed a 62.50% gain in the last 1 month and extending the period to 3 months gives it a -1.48%, and is -11.17% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 9.69% over the week and 12.76% over the month.

Solid Biosciences Inc (SLDB) has around 88 employees, a market worth around $406.78M and $0.00M in sales. Distance from 52-week low is 85.07% and -64.58% from its 52-week high. The company has generated returns on investments over the last 12 months (-54.21%).

The EPS is expected to grow by 39.19% this year, but quarterly earnings will post 0.00% year-over-year. Quarterly sales are estimated to shrink 0.00% in year-over-year returns.

The shares outstanding are 76.32M, and float is at 58.64M with Short Float at 5.02%.

Solid Biosciences Inc (SLDB) Insider Activity

The most recent transaction is an insider purchase by Bain Capital Life Sciences Inv, the company’s 10% Owner. SEC filings show that Bain Capital Life Sciences Inv bought 1,000,000 shares of the company’s common stock on Feb 19 ’25 at a price of $4.03 per share for a total of $4.03 million. Following the purchase, the insider now owns 5.03 million shares.

Solid Biosciences Inc disclosed in a document filed with the SEC on Feb 19 ’25 that PERCEPTIVE ADVISORS LLC (Director) bought a total of 5,000,000 shares of the company’s common stock. The trade occurred on Feb 19 ’25 and was made at $4.03 per share for $20.15 million. Following the transaction, the insider now directly holds 11.83 million shares of the SLDB stock.

Still, SEC filings show that on Feb 18 ’25, Adage Capital Management, L.P. (10% Owner) acquired 252,545 shares at an average price of $7.56 for $1.91 million. The insider now directly holds 4,248,084 shares of Solid Biosciences Inc (SLDB).

Related Posts